ABOUT LUMINATE

Making Cancer Care More Human

Y-Combinator Backed

Europe's Fastest Growing MedTech Startup

ABOUT LUMINATE

Making Cancer Care More Human

Y-Combinator Backed

Europe's Fastest Growing MedTech Startup

ABOUT LUMINATE

Making Cancer Care More Human

Y-Combinator Backed

Europe's Fastest Growing MedTech Startup

We’re here to reimagine cancer care, because the system isn’t working for the people in it.

We focus on the parts of cancer care that often go overlooked: the side effects, the burden on clinics, and the emotional toll on patients.

Everything we build is shaped by the people who use it - patients, providers, and partners alike.

Trusted by leading healthcare and tech investors
Trusted by leading healthcare and tech investors
Trusted by leading healthcare and tech investors

Our Journey
So Far

2019
Luminate begins

At the University of Galway, when medical device researchers Aaron Hannon, Dr. Bárbara Oliveira, and Prof. Martin O’Halloran were inspired to tackle chemotherapy-related side effects through technology, starting with hair loss. Enterprise Ireland's Commercialisation Fund grant helped kickstart our journey

2019
Luminate begins

At the University of Galway, Aaron Hannon, Dr. Bárbara Oliveira, and Prof. Martin O’Halloran were inspired to address the side effects of chemotherapy through medical device technolgy, starting with hair loss.

2019
Luminate begins

At the University of Galway, when medical device researchers Aaron Hannon, Dr. Bárbara Oliveira, and Prof. Martin O’Halloran were inspired to tackle chemotherapy-related side effects through technology, starting with hair loss. Enterprise Ireland's Commercialisation Fund grant helped kickstart our journey

2021
Spin-out + accelerate into Y Combinator

Joined Y Combinator’s Summer 2021 batch alongside alumni like Airbnb, Stripe, and Dropbox, and validated our hair-loss prevention technology while completing our first fundraise

2021
Spun out of University of Galway, Acclerated into Y Combinator

Joined Y Combinator’s Summer 2021 batch alongside alumni like Airbnb, Stripe, and Dropbox, and validated our hair-loss prevention technology while completing our first fundraise.

2021
Spin-out + accelerate into Y Combinator

Joined Y Combinator’s Summer 2021 batch alongside alumni like Airbnb, Stripe, and Dropbox, and validated our hair-loss prevention technology while completing our first fundraise

2022
Building momentum: Raise €2.1M in DTIF funding, and €2.5M in Seed Funding from SciFounders, Elkstone, and Faber

Secured €4.7M in funding to advance Lily, and support clinical trials across the U.S. and EU. Momentum starts to build from our Galway HQ to New York, we grow our R&D team, welcoming product designers, clinicians, and engineers

2022
Building momentum: Raise €2.1M in DTIF funding, and €2.5M in Seed Funding from SciFounders, Elkstone, and Faber

Secured €4.7M in funding to advance Lily, and support clinical trials across the US and EU. Momentum starts to build from our Galway HQ to New York, we grow our R&D team, adding product designers, clinicians, and engineers.

2022
Building momentum: Raise €2.1M in DTIF funding, and €2.5M in Seed Funding from SciFounders, Elkstone, and Faber

Secured €4.7M in funding to advance Lily, and support clinical trials across the U.S. and EU. Momentum starts to build from our Galway HQ to New York, we grow our R&D team, welcoming product designers, clinicians, and engineers

2023
Awarded second DTIF for €4.4m, demonstrate first evidence of prevention of hair loss and peripheral neuropathy in human chemotherapy patients

2023
Awarded second DTIF for €4.4m, demonstrate first evidence of prevention of hair loss and peripheral neuropathy in human chemotherapy patients

2023
Awarded second DTIF for €4.4m, demonstrate first evidence of prevention of hair loss and peripheral neuropathy in human chemotherapy patients

2024
Raise €15m in Series A funding led by ARTIS and 8VC, start first US-based multi center clinical trial for Lily

2024
Raise €15m in Series A funding led by ARTIS and 8VC, start first US-based multi center clinical trial for Lily

2024
Raise €15m in Series A funding led by ARTIS and 8VC, start first US-based multi center clinical trial for Lily

2025
Launched clinical trials in the U.S. for Lilac, awarded third DTIF for €6.5m, reached 50 team members in Galway

2025
Launched clinical trials in the U.S. for Lilac, awarded third DTIF for €6.5m, reached 50 team members in Galway

2025
Launched clinical trials in the U.S. for Lilac, awarded third DTIF for €6.5m, reached 50 team members in Galway

Featured in

Featured in

Featured in

Meet the team behind the work

Our team brings together clinical insight, technical depth, and a shared belief that better care is possible. Together, we’re building tools that make a measurable difference.

Leadership
Dr Bárbara Oliveira

CCO and Co-Founder

Conor Macken, CFO
Conor Macken

Chief Financial Officer

Aaron Hannon

CEO and Co-Founder

Prof. Martin O'Halloran

Co-Founder and Executive Director of BioInnovate

Emmet Frawley

VP RA/QA

Dr Ellen Cahill

VP R&D and Operations

Board
Steve Pacelli

Chairman

Austin Walne

Board Member

Dr Bobby Green

Board Member

Dr Bárbara Oliveira

CCO and Co-Founder

Aaron Hannon

CEO and Co-Founder

Full Team
Aaron Hannon

CEO and Co-Founder

Aaron McCormack

R&D Manager

Adriana Arriaga

Senior Product Designer

Aidan Curley

Senior Manufacturing Engineer

Meet the team behind the work

Our team brings together clinical insight, technical depth, and a shared belief that better care is possible. Together, we’re building tools that make a measurable difference.

Leadership
Dr Bárbara Oliveira

CCO and Co-Founder

Conor Macken, CFO
Conor Macken

Chief Financial Officer

Aaron Hannon

CEO and Co-Founder

Prof. Martin O'Halloran

Co-Founder and Executive Director of BioInnovate

Emmet Frawley

VP RA/QA

Dr Ellen Cahill

VP R&D and Operations

Board
Steve Pacelli

Chairman

Austin Walne

Board Member

Dr Bobby Green

Board Member

Dr Bárbara Oliveira

CCO and Co-Founder

Aaron Hannon

CEO and Co-Founder

Full Team
Aaron Hannon

CEO and Co-Founder

Aaron McCormack

R&D Manager

Meet the team behind the work

Our team brings together clinical insight, technical depth, and a shared belief that better care is possible. Together, we’re building tools that make a measurable difference.

Leadership
Dr Bárbara Oliveira

CCO and Co-Founder

Conor Macken, CFO
Conor Macken

Chief Financial Officer

Aaron Hannon

CEO and Co-Founder

Prof. Martin O'Halloran

Co-Founder and Executive Director of BioInnovate

Emmet Frawley

VP RA/QA

Dr Ellen Cahill

VP R&D and Operations

Board
Steve Pacelli

Chairman

Austin Walne

Board Member

Dr Bobby Green

Board Member

Dr Bárbara Oliveira

CCO and Co-Founder

Aaron Hannon

CEO and Co-Founder

Full Team
Aaron Hannon

CEO and Co-Founder

Aaron McCormack

R&D Manager

Adriana Arriaga

Senior Product Designer

Aidan Curley

Senior Manufacturing Engineer

On trial at leading
medical institutions
Trusted by leading healthcare and tech investors
Trusted by leading healthcare and tech investors

Building Europe's fastest growing MedTech startup

We’re a team of engineers, designers, clinicians, and researchers working together to make care more human.

Build the future of cancer care with us and help us to help patients.

Building Europe's fastest growing MedTech startup

We're a team of engineers, designers, clinicians, and researchers working together to make care more human

Build the future of cancer care with us and help us to help patients.

Building Europe's fastest growing MedTech startup

We’re a team of engineers, designers, clinicians, and researchers working together to make care more human.

Build the future of cancer care with us and help us to help patients.

We build technologies that help oncologists make cancer care better for patients.

People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.

Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.

FUNDED BY

On Trial At

Featured In

©2025 Luminate Medical. All Rights Reserved

We build technologies that help oncologists make cancer care better for patients.

People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.

Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.

FUNDED BY

On Trial At

Featured In

©2025 Luminate Medical. All Rights Reserved

We build technologies that help oncologists make cancer care better for patients.

People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.

Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.

FUNDED BY

On Trial At

Featured In

©2025 Luminate Medical. All Rights Reserved